Figure 4
Figure 4. iDCZol+ induce the expansion of CM and EM γδ T cells with specific homing and costimulatory receptors. (A) Representative dot plots of γδ T-cell subset distribution after 7 days stimulation with iDCZol− and iDCZol+. Four subsets are identified according to the expression of cell surface CD45RA and CD27 antigens after backgating on γδ T cells: naive (N: CD45RA+, CD27+), central memory (CM: CD45RA−, CD27+), effector memory (EM: CD45RA−, CD27−), and terminally differentiated late effector cells (TEMRA: CD45RA+, CD27−). (B) Total counts of γδ T-cell subsets after 7 days stimulation with iDCZol− and iDCZol+. Bars represent the mean ± SEM of 5 experiments. Differences between CM and EM γδ T cells are statistically significant (CM γδ T cells: iDCZol− 3600 ± 1400 versus iDCZol+ 54 000 ± 20 000; P < .03; EM γδ T cells: iDCZol− 4700 ± 2100 versus iDCZol+ 28 000 ± 11 000; P < .04). (C) Expression of homing receptors (CD62L) and costimulatory molecules (HLA-DR, CD80) on the surface of γδ T cells after stimulation with iDCZol+. Results are from 1 of 5 experiments. (D) Total counts of viable CD62L+, CD80+, and HLA-DR+ γδ T cells after stimulation with iDCZol+. Bars represent the mean (± SEM) of 5 experiments. Total counts of viable CD62L+ γδ T cells per well are significantly increased (CD62L+ γδ T cells: iDCZol− 13 500 ± 5300 versus iDCZol+ 62 000 ± 9000; P < .005; HLA-DR+ γδ T cells: iDCZol− 12 000 ± 4000 versus iDCZol+ 78 400 ± 21 000; P > .05; CD80+ γδ T cells: iDCZol− 4000 ± 1200 versus iDCZol+ 36 000 ± 16 000; P > .05).

iDCZol+ induce the expansion of CM and EM γδ T cells with specific homing and costimulatory receptors. (A) Representative dot plots of γδ T-cell subset distribution after 7 days stimulation with iDCZol− and iDCZol+. Four subsets are identified according to the expression of cell surface CD45RA and CD27 antigens after backgating on γδ T cells: naive (N: CD45RA+, CD27+), central memory (CM: CD45RA, CD27+), effector memory (EM: CD45RA, CD27), and terminally differentiated late effector cells (TEMRA: CD45RA+, CD27). (B) Total counts of γδ T-cell subsets after 7 days stimulation with iDCZol− and iDCZol+. Bars represent the mean ± SEM of 5 experiments. Differences between CM and EM γδ T cells are statistically significant (CM γδ T cells: iDCZol− 3600 ± 1400 versus iDCZol+ 54 000 ± 20 000; P < .03; EM γδ T cells: iDCZol− 4700 ± 2100 versus iDCZol+ 28 000 ± 11 000; P < .04). (C) Expression of homing receptors (CD62L) and costimulatory molecules (HLA-DR, CD80) on the surface of γδ T cells after stimulation with iDCZol+. Results are from 1 of 5 experiments. (D) Total counts of viable CD62L+, CD80+, and HLA-DR+ γδ T cells after stimulation with iDCZol+. Bars represent the mean (± SEM) of 5 experiments. Total counts of viable CD62L+ γδ T cells per well are significantly increased (CD62L+ γδ T cells: iDCZol− 13 500 ± 5300 versus iDCZol+ 62 000 ± 9000; P < .005; HLA-DR+ γδ T cells: iDCZol− 12 000 ± 4000 versus iDCZol+ 78 400 ± 21 000; P > .05; CD80+ γδ T cells: iDCZol− 4000 ± 1200 versus iDCZol+ 36 000 ± 16 000; P > .05).

Close Modal

or Create an Account

Close Modal
Close Modal